• Thompson LU, Boucher BA, Lui Z, et al.
    Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans and coumestan.
    Nutrition and Cancer. 2006;54:184-201.
  • Castle EP, Thrasher JB.
    The role of soy phytoestrogens in prostate cancer.
    Urol Clin North Am. 2002; 29:71-81.
  • Mazur W, Adlercreutz H.
    Naturally occurring estrogens in food.
    Pure & Applied Chem. 1998;70:1759-1776.
  • Setchell, D. R.
    Soy Isoflavones-benefits and risks from nature’s selective estrogen receptor modulators (SERMs).
    J Am Coll Nutr. 2001;20:354S-362S.
  • MacMahon B, Cole P, Brown J.
    Etiology of human breast cancer: a review.
    J Natl Cancer Inst. 1973;50:21-42.
  • Adlercreutz H, et al.
    Phytoestrogens and Prostate Disease.
    J. Nutr. 2000;130:658S-659S.
  • Birt DF, Hendrich S, Wang W.
    Dietary agents in cancer prevention: flavonoids and isoflavonoids.
    Pharmacol Ther. 2001;90:157-161.
  • Setchell KD
    Exposure of infants to phyto-oestrogens from soy-based infant formula.
    Lancet. 1997;350:23-27.
  • Cantani A, Lucenti P.
    Natural history of soy allergy and/or intolerance in children, and clinical use of soy-protein formulas.
    Pediatric Allergy Immunology. 1997;8:59-74.
  • Doerge DR, Sheehan DM.
    Goitrogenic and estrogenic activity of soy isoflavones
    Environ Health Perspect. 2002;3:349-353.
  • Divi RL, Chang HC, Doerge DR.
    Anti-thyroid isoflavones from soybean: isolation, characterization, and mechanisms of action.
    Biochem Pharmacol. 1997;54:1087.